Cardiac

  • An image of Edwards Lifesciences' Irvine, California, campus at dusk.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards focuses on earlier TAVR adoption

    The heart valve specialist reported a second straight quarter of double-digit TAVR sales growth and credited recent study results with driving a “sense of urgency” for treating patients.

    By • Feb. 11, 2026
  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    4 takeaways from the 2026 AF Symposium

    Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation treatments, including pulsed field ablation catheters.

    By • Feb. 10, 2026
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendline➔
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • A picture of a medical catheter against a white background.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott details Volt, TactiFlex data; Pulse Biosciences’ results shine

    Abbott and Pulse released their findings at the AF Symposium that wrapped this weekend in Boston.

    By • Feb. 9, 2026
  • FDA
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA breakthrough program starts FY2026 at steady pace

    Orthopedics was the most active area over the second half of 2025, with the FDA issuing 13 breakthrough designations to devices in the therapeutic area.

    By • Feb. 9, 2026
  • Illustration of a heart with a metal, coiled wire going into it.
    Image attribution tooltip
    Courtesy of Abiomed
    Image attribution tooltip

    J&J corrects Impella heart pumps over issue linked to 22 serious injuries

    The urgent correction notice is the latest in a series of actions related to the safety of Impella devices.

    By • Feb. 4, 2026
  • The CathWorks FFRangio System on a cart.
    Image attribution tooltip
    Permission granted by CathWorks
    Image attribution tooltip

    Medtronic to acquire CathWorks for up to $585M

    The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery disease.

    By • Feb. 3, 2026
  • Edwards Lifesciences' Sapien 3 Ultra heart valve replacement system is shown with the valve expanded by a balloon.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards’ request for broader TAVR Medicare coverage gets pushback

    Several medical societies supported extending Medicare coverage for TAVR to patients with asymptomatic aortic stenosis, but some physicians and rival Medtronic said more data is needed.

    By • Jan. 28, 2026
  • Three clinicians work with a robotic surgery system as a patient lies on the operating table.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip
    Deep Dive

    5 robotic surgery trends to watch in 2026

    Soft tissue robotic systems designed to improve surgical precision are expanding into new specialties and increasing competition for longtime industry leader Intuitive Surgical.

    By • Jan. 27, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic wins CE mark for single-shot pulsed field ablation catheter

    Medtronic’s Affera Sphere-360 is a single-shot device, putting it in direct competition with Boston Scientific’s Farawave catheter.

    By • Jan. 26, 2026
  • Two clinicians wearing scrubs stand in front of Intuitive Surgical's da Vinci 5 robotic surgery system.
    Image attribution tooltip
    Courtesy of Tampa General Hospital
    Image attribution tooltip

    Intuitive’s cardiac initiative includes valve repair, LAA closure

    With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S. sites this year to establish cardiac programs.

    By • Jan. 26, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott posts Q4 sales below expectations

    Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the company’s shares.

    By • Jan. 22, 2026
  • An artificial heart valve is pictured against a white background.
    Image attribution tooltip
    Retrieved from Anteris Technologies Global on January 21, 2026
    Image attribution tooltip

    Medtronic to buy up to $90M stake in heart valve developer Anteris

    Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

    By • Jan. 21, 2026
  • Abbott Laboratories
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott gets Europe’s CE mark for dual ablation catheter

    The device can deliver both radiofrequency energy and pulsed field ablation to treat heart arrhythmias.

    By • Jan. 20, 2026
  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific to acquire Penumbra for $14.5B

    With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

    By • Jan. 15, 2026
  • Boston Scientific's Farapoint pulsed field ablation catheter is shown against a white background.
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip

    Boston Scientific gains FDA’s OK for new PFA catheter

    The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain its electrophysiology market share, one analyst said.

    By • Jan. 14, 2026
  • A corporate building for Edwards Lifesciences.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards calls off JenaValve buyout after court halts deal

    Edwards terminated the deal after the Federal Trade Commission moved to block the acquisition due to anticompetitive concerns.

    By • Jan. 12, 2026
  • A person walks toward a door while carrying a briefcase.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Teleflex CEO leaving company

    Stuart Randle, who retired in 2018, has replaced Liam Kelly as CEO and president on an interim basis.

    By • Jan. 9, 2026
  • Stereotaxis' GenesisX surgical robot is shown against a white background.
    Image attribution tooltip
    Permission granted by Stereotaxis
    Image attribution tooltip

    Stereotaxis wins FDA approval for robotically navigated ablation catheter

    Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a J&J catheter.

    By • Jan. 7, 2026
  • A 3D visualization of red blood cells traveling through a blood vessel.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Biobeat raises $50M to commercialize cuffless blood pressure monitor

    The company will use the money to try to establish its cuffless device as a go-to option for 24-hour blood pressure monitoring in the U.S.

    By • Jan. 6, 2026
  • Close up of a white cylindrical device.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards receives FDA approval for mitral valve replacement system

    The Sapien M3 device is the first approved mitral regurgitation treatment to use a transseptal approach, Edwards said.

    By • Dec. 23, 2025
  • FDA
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA posts Class I recall notice about Medtronic heart vent catheters

    The company received three complaints about patients who had perforation injuries linked to the devices.

    By • Dec. 23, 2025
  • A picture of a medical catheter against a white background.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott receives FDA approval for Volt PFA system

    Abbott can now compete with Medtronic, Boston Scientific and J&J in the U.S. for the fast-growing pulsed field ablation market.

    By • Dec. 22, 2025
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott receives clearance for heart delivery device in premature babies

    Physician feedback has informed a delivery device designed to make procedures safer and easier.

    By • Dec. 22, 2025
  • FDA sign
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Pulse Biosciences wins FDA approval to begin PFA catheter study

    Shorter, nanosecond pulses for treating atrial fibrillation differentiate the company’s approach from existing pulsed field ablation systems on the market.

    By • Dec. 18, 2025
  • Edwards Lifesciences' Sapien 3 Ultra heart valve replacement system is shown with the valve expanded by a balloon.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    CMS considers expanding TAVR coverage to asymptomatic patients

    Medicare reimbursement for aortic stenosis patients without symptoms could accelerate procedure growth for Edwards Lifesciences, which requested the CMS review, analysts said.

    By • Dec. 16, 2025